Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Fund Letter | Ben Pirie & Nicholas CortellucciAtrium Research | -- | Long LOVE.TO (Cannara Biotech Inc.) On July 15th, Cannara Biotech Inc. (LOVE:TSX, LOVFF:OTC, BUY $3.00 Target) reported record Q3/26 revenue of $31.8M (+16% YoY) and adjusted EBITDA of $8.5M (+11% YoY), both ahead of our estimates and marking a rebound from the seasonally soft Q2. Gross revenue reached... | BULL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | Ben Pirie & Nicholas CortellucciAtrium Research | -- | Atrium Research - LOVE.TO This morning, Cannara Biotech Inc. (LOVE:TSX, LOVFF:OTCQX, FRA:8CB0) reported its Q3/26 earnings that came in ahead of our estimates, with revenue of $31.8M (+16% YoY) and Adjusted EBITDA of $8.5M (+11% YoY). The quarter marked... | NEUTRAL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.